EUVIMEDEUVIMED entdecken
Crossref

Amiodarone-induced Thyrotoxicosis: diagnosis and clinical management

Lohany Duarte de Sousa, Samara Franco Teles, Madalena da Silva Pereira, Mannuelly Machado Bastos, Marcio Vinicius Carvalho Coelho, Ana Beatriz Bezerra Furlan, Maria Eduarda de Lima Dacier Lobato, Márcia Cristina Guimarães Preti

Cuadernos de Educación y Desarrollo · 22.06.2026 · 18 (6) · e11006

DOI: 10.55905/cuadv18n6-030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cuadernos de Educación y Desarrollo, online erschienen am 22.06.2026. Verfasst von Lohany Duarte de Sousa und 7 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amiodarone-induced thyrotoxicosis (AIT) is a severe endocrine complication resulting from the iodine overload present in this antiarrhythmic drug, capable of exacerbating underlying cardiac anomalies and increasing mortality risk. This work consists of an integrative literature review, focusing on scientific productions published between 2021 and 2026, aiming to elucidate the differential diagnosis and therapeutic strategies for AIT. The pathology is classically divided into two main subtypes. Type 1 AIT occurs in glands with prior diseases, resulting in hormonal overproduction, whereas Type 2 AIT is characterized by a destructive thyroiditis in normal glands. Accurate diagnosis between subtypes requires laboratory evaluation combined with imaging tests, such as color Doppler ultrasonography and radionuclide evaluation. Therapeutic management must be individualized: Type 1 AIT is treated with high-dose antithyroid drugs, which may be associated with perchlorates; Type 2 AIT, however, responds better to corticosteroids. Adjuvant therapies, such as cholestyramine, prove useful in refractory cases. Finally, in patients with severe cardiovascular instability or clear clinical failure, thyroidectomy acts as a mandatory rescue intervention. A deep understanding of AIT diagnosis and management is therefore essential to preserve the myocardium and the survival of cardiac patients

Zitieren

APA

Sousa, L. D. D., Teles, S. F., Pereira, M. D. S., Bastos, M. M., Coelho, M. V. C., Furlan, A. B. B., Lobato, M. E. D. L. D., & Preti, M. C. G. (2026). Amiodarone-induced Thyrotoxicosis: diagnosis and clinical management. Cuadernos de Educación y Desarrollo, 18(6), e11006. https://doi.org/10.55905/cuadv18n6-030

Vancouver

Sousa LDD, Teles SF, Pereira MDS, Bastos MM, Coelho MVC, Furlan ABB, et al. Amiodarone-induced Thyrotoxicosis: diagnosis and clinical management. Cuadernos de Educación y Desarrollo. 2026;18(6):e11006. doi:10.55905/cuadv18n6-030

BibTeX
@article{Sousa2026,
  author = {Sousa, Lohany Duarte de and Teles, Samara Franco and Pereira, Madalena da Silva and Bastos, Mannuelly Machado and Coelho, Marcio Vinicius Carvalho and Furlan, Ana Beatriz Bezerra and Lobato, Maria Eduarda de Lima Dacier and Preti, Márcia Cristina Guimarães},
  title = {Amiodarone-induced Thyrotoxicosis: diagnosis and clinical management},
  journal = {Cuadernos de Educación y Desarrollo},
  year = {2026},
  volume = {18},
  number = {6},
  pages = {e11006},
  doi = {10.55905/cuadv18n6-030}
}
Kostenlos starten →